These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 8818892)
1. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks. Zerva L; Biedenbach DJ; Jones RN J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae. Powell M; Williams JD Antimicrob Agents Chemother; 1987 Dec; 31(12):1871-3. PubMed ID: 3501940 [TBL] [Abstract][Full Text] [Related]
3. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin. Powell M; Seetulsingh P; Williams JD J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206 [TBL] [Abstract][Full Text] [Related]
4. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae. Doern GV; Daum GS; Tubert TA J Clin Microbiol; 1987 Sep; 25(9):1675-8. PubMed ID: 3498738 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains. Miyazaki S; Fujikawa T; Kanazawa K; Yamaguchi K J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563 [TBL] [Abstract][Full Text] [Related]
6. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin. Jorgensen JH; Maher LA; Howell AW Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214 [TBL] [Abstract][Full Text] [Related]
7. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin. Jones RN; Erwin ME Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050 [TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid]. Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae. Cerami AT; Shungu DL Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437 [TBL] [Abstract][Full Text] [Related]
10. Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae. Barrett MS; Jones RN Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):462-5. PubMed ID: 1330563 [TBL] [Abstract][Full Text] [Related]
11. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines. Heelan JS; Chesney D; Guadagno G J Clin Microbiol; 1992 Jul; 30(7):1674-7. PubMed ID: 1629320 [TBL] [Abstract][Full Text] [Related]
12. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Mendelman PM; Chaffin DO; Clausen C; Stull TL; Needham C; Williams JD; Smith AL Antimicrob Agents Chemother; 1986 Aug; 30(2):274-80. PubMed ID: 3490217 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities to 23 antimicrobial agents of Haemophilus influenzae from pediatric patients in Japan. Matsuo Y Kurume Med J; 2000; 47(3):205-10. PubMed ID: 11059221 [TBL] [Abstract][Full Text] [Related]
14. Imipenem and meropenem activity against mecA-positive homogeneously and heterogeneously oxacillin-resistant and mecA-negative oxacillin-borderline-susceptible staphylococci. Knapp CC; Ludwig MD; Washington JA Diagn Microbiol Infect Dis; 1997 Jun; 28(2):81-6. PubMed ID: 9239499 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C; Xie W; Zhang W; Ye Z; Wu H Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial effects of meropenem and imipenem against Haemophilus influenzae. Yourassowsky E; Van der Linden MP; Crokaert F Chemotherapy; 1991; 37(1):38-42. PubMed ID: 2013240 [TBL] [Abstract][Full Text] [Related]
17. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium. Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268 [TBL] [Abstract][Full Text] [Related]
18. Effect of the inoculum size on carbapenem susceptibilities of beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae. Miyazaki H; Horii T; Nagura O; Suda T; Chida K; Nakamura H Curr Microbiol; 2009 Jan; 58(1):18-24. PubMed ID: 18815831 [TBL] [Abstract][Full Text] [Related]
19. [A simple disk diffusion test to identify beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae--application of cephalexin, cefsulodin and cefaclor disks]. Endo R; Yamane N; Tamayose MH; Uchibori KK; Nakasone I Rinsho Byori; 2010 Oct; 58(10):963-71. PubMed ID: 21077285 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions. Hirakata Y; Ohmori K; Mikuriya M; Saika T; Matsuzaki K; Hasegawa M; Hatta M; Yamamoto N; Kunishima H; Yano H; Kitagawa M; Arai K; Kawakami K; Kobayashi I; Jones RN; Kohno S; Yamaguchi K; Kaku M Antimicrob Agents Chemother; 2009 Oct; 53(10):4225-30. PubMed ID: 19651910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]